Skip to Content

Bolivia

  Chagas disease is endemic in the gran chaco region, which borders Paraguay, argentina and Bolivia. In november 2010, Msf began a chagas diagnosis and treatment programme in Paraguay. Photo: MSF Chagas disease is one of the leading parasitic killers in the Americas and Bolivia is the country most affected. If not treated in the early stages, Chagas can cause cardiovascular, gastrointestinal or neurological problems later in life. Diagnosis is complicated, and the Bolivian Ministry of Health does not have adequate financial or human resources to diagnose and treat the disease across the whole country. The Ministry concentrates on treating young people with Chagas disease because treatment...
29 June 2011
Henry Rodríguez, general coordinator for MSF in Bolivia and Paraguay
Henry Rodríguez, general coordinator for MSF in Bolivia and Paraguay
“We are wasting the opportunity to put people who need it on Chagas treatment.”  Chagas projects in Bolivia and Paraguay have seen their capacity to treat patients limited due to a shortage in the first-line drug benznidazol. Only one laboratory in Brazil makes the drug, and manufacturing has been delayed. Henry Rodríguez, general coordinator for MSF in Bolivia and Paraguay, describes the situation in MSF projects in those countries.   Photo: MSF What is the impact on projects of the delay in benznidazol? No new treatment can be started until we have more drugs because we can’t risk having to interrupt patients’ treatment. If treatment is stopped for longer than a...
Syndicate content